Package 17856-1133-4

{"route": ["ORAL"], "spl_id": "3fb79d29-e4a9-4102-e063-6294a90ac064", "openfda": {"nui": ["N0000175557", "N0000011310"], "unii": ["27O7W4T232"], "rxcui": ["104232"], "spl_set_id": ["122558a0-57bb-4195-9adf-d37b049cbfb5"], "pharm_class_epc": ["Aldosterone Antagonist [EPC]"], "pharm_class_moa": ["Aldosterone Antagonists [MoA]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 BAG (17856-1133-1)  / 2.5 mL in 1 SYRINGE", "package_ndc": "17856-1133-1", "marketing_start_date": "20240603"}, {"sample": false, "description": "1 SYRINGE in 1 BAG (17856-1133-4)  / 2.5 mL in 1 SYRINGE", "package_ndc": "17856-1133-4", "marketing_start_date": "20250926"}], "brand_name": "SPIRONOLACTONE", "product_id": "17856-1133_3fb79d29-e4a9-4102-e063-6294a90ac064", "dosage_form": "SUSPENSION", "pharm_class": ["Aldosterone Antagonist [EPC]", "Aldosterone Antagonists [MoA]"], "product_ndc": "17856-1133", "generic_name": "spironolactone", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SPIRONOLACTONE", "active_ingredients": [{"name": "SPIRONOLACTONE", "strength": "25 mg/5mL"}], "application_number": "NDA209478", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20231031", "listing_expiration_date": "20261231"}